Display:

Keyword Search: Treatment
1 Article
Source: CBS News

New treatment "a breakthrough" for kids with peanut allergies, study finds

Today 19:07 GMT

The researchers gave a third of the participants a placebo, while two-thirds received oral doses of small amounts of peanut protein powder in increasing amounts until reaching the "maintenance dose," equivalent of one peanut a day.

"This is not a quick fix, and it doesn't mean people with peanut allergy will be able to eat peanuts whenever they want," Dr. Jay Lieberman, co-author of the study and vice chair of the American College of Allergy, Asthma and Immunology Food Allergy Committee, said in a statement. "But it is definitely a breakthrough."

1 Article
Source: Common Domain

Novartis CEO Bets on Cutting-Edge Science to Remake Drug Giant

Today 08:05 GMT

“We thought if we could gain a leadership position it’d be harder for competition to take us on,” Dr. Narasimhan, who led drug development at Novartis before becoming CEO, said in an interview.

Novartis struck a licensing deal in January giving it the right to sell Spark Therapeutic Inc.’s gene therapy for a rare eye disorder in Europe and other markets outside the U.S.. None of the new acquisitions are likely to generate a fast return for Novartis.

1 Article
Source: Global News

New trial shows allergy treatment helps protect children against peanut reactions

Monday 20:55 GMT

A new treatment for peanut allergy appears to allow children who are severely allergic to consume a small amount of peanut — potentially protecting them from having a reaction if they accidentally eat some.

According to a clinical trial of about 500 children aged four to 17 published in the New England Journal of Medicine, about 76 per cent of children, who were initially only able to eat about half a peanut without a severe reaction, were able to eat the equivalent of one whole peanut after completing the immunotherapy treatment.

1 Article
Source: The Week

Insurers play a huge part in America's opioid epidemic

Sunday 11:44 GMT

As parts of America struggle with widespread opioid addiction, communities are trying various techniques to attempt to bring rates down.

Subscribe to the magazine's newsletter and follow Pacific Standard on Twitter to support journalism in the public interest.


“Four hostile newspapers are more to be feared than a thousand bayonets...” ― Napoléon Bonaparte